Your browser doesn't support javascript.
loading
Is locally advanced head and neck cancer 'increasing' in the Netherlands? The paradox of absolute numbers, standardized incidence rates and proportional share.
van Beers, M A; Schreuder, W H; Balm, A J M; van Dijk, B A C.
Afiliação
  • van Beers MA; Department of Head and Neck Oncology & Surgery, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: maartjevanbeers@hotmail.com.
  • Schreuder WH; Department of Head and Neck Oncology & Surgery, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Oral and Maxillofacial Surgery, AmsterdamUMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Balm AJM; Department of Head and Neck Oncology & Surgery, Antoni van Leeuwenhoek/Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Oral and Maxillofacial Surgery, AmsterdamUMC, University of Amsterdam, Amsterdam, The Netherlands.
  • van Dijk BAC; Netherlands Comprehensive Cancer Organization (IKNL), Department of Research and Development, Utrecht, The Netherlands; University of Groningen, University Medical Centre Groningen, Department of Epidemiology, Groningen, The Netherlands.
Oral Oncol ; 138: 106316, 2023 03.
Article em En | MEDLINE | ID: mdl-36709706
ABSTRACT

BACKGROUND:

Several reports have indicated that locally advanced head and neck cancer (LAHNC) has increased in the past decade. However, incidence trends cannot be easily compared because slightly different definitions of LAHNC were used.

AIM:

To investigate if the incidence of locally advanced disease (LAD) in the oral cavity, oropharynx, hypopharynx and larynx is indeed increasing over time, considering the growing and ageing population in the Netherlands. PATIENTS AND

METHODS:

Data were obtained from the Netherlands Cancer Registry (NCR). Primary head and neck squamous cell carcinomas of the oral cavity, oropharynx, hypopharynx and larynx diagnosed between 1989 and 2017 were included. Yearly numbers and European standardized incidence rates (ESRs) were reported by extent of disease. The annual percentage change (APC) over time in ESRs was calculated to assess trends.

RESULTS:

Absolute numbers and ESRs of LAD increased over time for oral cavity and most prominently for oropharynx carcinomas (before 1996, APC 0.4, 95%CI 0.1; 0.8 and APC 5.7 (95%CI 3.1; 8.4) after 1996 1.5 (1.0; 2.0) respectively. For hypopharynx cancer the absolute number and ESR of LAD increased until 1997 and declined with 0.8% per year since 1997. Absolute numbers of patients with larynx cancer stayed stable over time, while ESR decreased (APC -0.8 (95%CI -1.1; -0.6)).

CONCLUSION:

The perception of an increasing trend in LAD in the Netherlands can be attributed to the increasing incidence of oral cavity and oropharynx carcinomas. For LAD of the hypopharynx a decreasing trend was observed. In larynx cancer, the proportional share of LAD of the larynx increased, even though incidence rates declined.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Orofaríngeas / Neoplasias Laríngeas / Neoplasias de Cabeça e Pescoço Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Orofaríngeas / Neoplasias Laríngeas / Neoplasias de Cabeça e Pescoço Idioma: En Ano de publicação: 2023 Tipo de documento: Article